US EditionUnderstanding Major Depressive Disorder: Its Impact and Treatment Options
- Major depression is a common mental health condition in the U.S., affecting adolescents and adults, impacting relationships and daily life.
- Major depressive disorder lasts nearly daily for at least two weeks and may persist for years without treatment, affecting over 21 million people in the U.S.
- Approximately one-third of individuals with MDD do not respond to antidepressant medications, and 86% do not achieve symptom relief with a third treatment.
- Neurocrine Biosciences is conducting a Phase 3 study to evaluate osavampator as an adjunct treatment for adults with recurrent MDD who have not adequately responded to current medications.
Insights by Ground AI
Does this summary seem wrong?
96 Articles
96 Articles
All
Left
5
Center
28
Right
7
No More Trial and Error: Brain Scans May Soon Predict the Best Antidepressant for You
Encouraging advances in predicting how patients with major depressive disorder (MDD) will respond to antidepressant treatments using brain imaging and clinical data. Finding an effective antidepressant can be a frustrating and lengthy process, often requiring individuals to spend weeks on medications that ultimately prove ineffective. However, a new study offers hope for a more personalized [...]
Coverage Details
Total News Sources96
Leaning Left5Leaning Right7Center28Last UpdatedBias Distribution70% Center
Bias Distribution
- 70% of the sources are Center
70% Center
13%
C 70%
R 18%
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
